ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
There are few data regarding ZAC1 expression in clinically non-functioning pituitary adenomas (NFPA). Because somatotropinomas and NFPA behave differently with respect to tumor shrinkage during somatostatin analogs (SA) therapy, we sought to compare the ZAC1 and somatostatin receptor (sstr) types 1,...
Main Authors: | Leonardo Vieria Neto, Luiz Eduardo Wildemberg, Leandro Machado Colli, Leandro Kasuki, Nelma Veronica Marques, Aline Barbosa Moraes, Emerson L Gasparetto, Christina Maeda Takiya, Margaret Castro, Mônica Roberto Gadelha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3788723?pdf=render |
Similar Items
-
Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
by: Leonardo Vieira Neto, et al.
Published: (2013-01-01) -
Correction: and Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas.
by: Leonardo Vieira Neto, et al.
Published: (2013-01-01) -
Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
by: Judit Dénes, et al.
Published: (2015-01-01) -
Expression of Somatostatin Receptor(SSTR) Subtypes in Pituitary Adenomas : Quantitative Analysis of SSTR2 mRNA by Reverse Transcription-Polymerase Chain Reaction
by: Murabe, Hiroyuki
Published: (2014) -
Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas
by: R.K. Foltran, et al.
Published: (2018-06-01)